Pramipeksolün mevsimsel depresyon üzerindeki etkinliği: olgu sunumu

Year 2023, Volume: 48 Issue: 2, 750 - 751, 02.07.2023

Osman Ozdemir

https://doi.org/10.17826/cumj.1276024

Abstract

Efficacy of pramipexole on seasonal depression: a case report

Abstract

The efficacy and safety of pramipexole have been reported both in the treatment of unipolar/bipolar depression and anxiety/depression in patients with Parkison disease. But, there is no evidence for its clinical effect in seasonal depressive disorder. In this case report, the patient with seasonal depression responded to pramipexole is presented.

Keywords

Pramipexole, seasonal depression, parkinsonism

References

• Fonte A, Coutinho B. Seasonal sensitivity and psychiatric morbidity: study about seasonal affective disorder. BMC Psychiatry. 2021;21:317.
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association. 2013.
• Tundo A, de Filippis R, De Crescenzo F. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and metaanalysis Acta Psychiatr Scand. 2019:140:116–25.
• Ji N, Meng P, Xu B, Zhou X. Efficacy and safety of pramipexole in Parkinson’s disease with anxiety or depression: a meta-analysis of randomized clinical trials. Am J Transl Res. 2022;14:1757-64.
• Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012;8:15-21